FDA Inspection 1070323 — Alk-abello, Inc.

Alk-abello, Inc. — FEI 2431784

The FDA completed an inspection of Alk-abello, Inc. on October 30, 2018 in Port Washington, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 30, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Port Washington, NY (United States)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products